Selecta Biosciences
SELB
#8964
Rank
$0.13 B
Marketcap
$0.88
Share price
-8.00%
Change (1 day)
-36.60%
Change (1 year)

Revenue for Selecta Biosciences (SELB)

Revenue in 2023 (TTM): $34.53 Million USD

According to Selecta Biosciences's latest financial reports the company's current revenue (TTM ) is $34.53 Million USD. In 2022 the company made a revenue of $0.11 Billion USD an increase over the revenue in the year 2021 that were of $85.07 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Selecta Biosciences from 2015 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) $34.53 M-68.83%
2022 $0.11 B30.21%
2021 $85.07 M412.6%
2020 $16.59 M148.57%
2019 $6.67 M639.42%
2018 $0.9 M336.23%
2017 $0.2 M-97.44%
2016 $8.08 M34.47%
2015 $6.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA